303 related articles for article (PubMed ID: 9294122)
1. Production and physiological actions of anandamide in the vasculature of the rat kidney.
Deutsch DG; Goligorsky MS; Schmid PC; Krebsbach RJ; Schmid HH; Das SK; Dey SK; Arreaza G; Thorup C; Stefano G; Moore LC
J Clin Invest; 1997 Sep; 100(6):1538-46. PubMed ID: 9294122
[TBL] [Abstract][Full Text] [Related]
2. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
4. Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels.
Grainger J; Boachie-Ansah G
Br J Pharmacol; 2001 Nov; 134(5):1003-12. PubMed ID: 11682448
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
[TBL] [Abstract][Full Text] [Related]
6. Effect of anandamide on nonadrenergic noncholinergic-mediated relaxation of rat corpus cavernosum.
Ghasemi M; Sadeghipour H; Mani AR; Tavakoli S; Hajrasouliha AR; Ebrahimi F; Dehpour AR
Eur J Pharmacol; 2006 Aug; 544(1-3):138-45. PubMed ID: 16824514
[TBL] [Abstract][Full Text] [Related]
7. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.
Molina-Holgado F; Molina-Holgado E; Guaza C; Rothwell NJ
J Neurosci Res; 2002 Mar; 67(6):829-36. PubMed ID: 11891798
[TBL] [Abstract][Full Text] [Related]
8. Systemic and portal hemodynamic effects of anandamide.
Garcia N; Járai Z; Mirshahi F; Kunos G; Sanyal AJ
Am J Physiol Gastrointest Liver Physiol; 2001 Jan; 280(1):G14-20. PubMed ID: 11123193
[TBL] [Abstract][Full Text] [Related]
9. Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed.
Poblete IM; Orliac ML; Briones R; Adler-Graschinsky E; Huidobro-Toro JP
J Physiol; 2005 Oct; 568(Pt 2):539-51. PubMed ID: 16081483
[TBL] [Abstract][Full Text] [Related]
10. Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide-independent coronary vasodilator effect of bradykinin in the rat.
Fulton D; Quilley J
J Pharmacol Exp Ther; 1998 Sep; 286(3):1146-51. PubMed ID: 9732371
[TBL] [Abstract][Full Text] [Related]
11. Morphine and anandamide coupling to nitric oxide stimulates GnRH and CRF release from rat median eminence: neurovascular regulation.
Prevot V; Rialas CM; Croix D; Salzet M; Dupouy JP; Poulain P; Beauvillain JC; Stefano GB
Brain Res; 1998 Apr; 790(1-2):236-44. PubMed ID: 9593913
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic nitric oxide synthase inhibition on the cardiovascular responses to cannabinoids in vivo and in vitro.
Wheal AJ; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 2007 Mar; 150(5):662-71. PubMed ID: 17245361
[TBL] [Abstract][Full Text] [Related]
13. Mesenteric vasodilation mediated by endothelial anandamide receptors.
Wagner JA; Varga K; Járai Z; Kunos G
Hypertension; 1999 Jan; 33(1 Pt 2):429-34. PubMed ID: 9931142
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves.
Ishac EJ; Jiang L; Lake KD; Varga K; Abood ME; Kunos G
Br J Pharmacol; 1996 Aug; 118(8):2023-8. PubMed ID: 8864538
[TBL] [Abstract][Full Text] [Related]
15. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
Adams IB; Compton DR; Martin BR
J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885
[TBL] [Abstract][Full Text] [Related]
16. Effects of hypertension on vasorelaxation to endocannabinoids in vitro.
Wheal AJ; Randall MD
Eur J Pharmacol; 2009 Jan; 603(1-3):79-85. PubMed ID: 19100733
[TBL] [Abstract][Full Text] [Related]
17. Anandamide decreases glomerular filtration rate through predominant vasodilation of efferent arterioles in rat kidneys.
Koura Y; Ichihara A; Tada Y; Kaneshiro Y; Okada H; Temm CJ; Hayashi M; Saruta T
J Am Soc Nephrol; 2004 Jun; 15(6):1488-94. PubMed ID: 15153559
[TBL] [Abstract][Full Text] [Related]
18. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P
FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries.
O'Sullivan SE; Kendall DA; Randall MD
Br J Pharmacol; 2004 Jun; 142(3):435-42. PubMed ID: 15148250
[TBL] [Abstract][Full Text] [Related]
20. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor.
Pratt PF; Hillard CJ; Edgemond WS; Campbell WB
Am J Physiol; 1998 Jan; 274(1):H375-81. PubMed ID: 9458889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
